RenovaCare products are under development and not approved for sale in the United States.
Results may vary from person to person.

Latest Press Releases

Dr. Emanual Maverakis, Recipient of Presidential Award for Scientists and Engineers, Joins RenovaCare

Scottsdale, AZ – November 26, 2019 – RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of tissues and organs, is pleased to announce the appointment of Dr. Emanual Maverakis to its Board of Advisors. Dr. Maverakis is a renowned professor at the University of California Davis School of Medicine, holding appointments in the Department of Dermatology and in the Department of Medical Microbiology and Immunology.

Read more

RenovaCare Appoints Alan L. Rubino as President and CEO

Scottsdale, AZ – November 18, 2019 – RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of tissues and organs, today announced the appointment of  Alan L. Rubino as President and Chief Executive Officer. Mr. Rubino will lead the Company through its next stages of clinical and corporate development and financial growth.

Read more

Company Overview

RenovaCare, Inc. is committed to the highest standards of ethical behavior and the Company’s commitment extends to all aspects of its role as an employer and as a corporate citizen. This commitment to ethical behavior extends beyond mere compliance with laws and regulations to inspire our relationships with our shareholders, clients, and employees.

Corporate Office:

RenovaCare, Inc.
94 Hundred Corporate Center,
9375 E Shea Blvd, Suite 107-A
Scottsdale, AZ 85260
1-888-398-0202

Sign Up for Investor Alerts